BEIGENE: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
BEIGENE: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
BEIGENE: APPOINTMENT OF MEMBER OF COMMERCIAL AND MEDICAL AFFAIRS ADVISORY COMMITTEE
BEIGENE: DATE OF AUDIT COMMITTEE MEETING
BEIGENE: INSIDE INFORMATION - BEIGENE RECEIVES FDA APPROVAL FOR TEVIMBRA (TISLELIZUMAB) FOR THE TREATMENT OF ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER PRIOR CHEMOTHERAPY
BEIGENE: SHARE PURCHASE PURSUANT TO THE EMPLOYEE SHARE PURCHASE PLAN
BEIGENE: EMPLOYEE SHARE PURCHASE PLAN
BEIGENE: Next Day Disclosure Return
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
BEIGENE: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
BEIGENE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
BEIGENE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
BEIGENE: Next Day Disclosure Return
BEIGENE: Next Day Disclosure Return
BEIGENE: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
BEIGENE: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
BEIGENE: Next Day Disclosure Return
BEIGENE: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-K
No Data